Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic...
Read More
Kidney Cancer Journal
Treatment patterns among patients with metastatic renal cell carcinoma receiving systemic therapies in US real-world settings between 2006 and 2017
Treatment patterns among patients with metastatic renal cell carcinoma receiving systemic...
Read More
Treatment of metastatic renal cell carcinoma with the mushroom toxin orellanine
Treatment of metastatic renal cell carcinoma with the mushroom toxin orellanine Abstract Poisoning...
Read More
TiNiVo: A Phase Ib Dose Escalation Trial of Tivozanib and Nivolumab in Renal Cell Carcinoma
TiNiVo: A Phase Ib Dose Escalation Trial of Tivozanib and Nivolumab in Renal Cell Carcinoma...
Read More
Three-Year Efficacy and Safety Update From the Phase III CheckMate 025 Study of Nivolumab Versus Everolimus in Patients With Advanced Renal Cell Carcinoma (aRCC)
Three-Year Efficacy and Safety Update From the Phase III CheckMate 025 Study of Nivolumab Versus...
Read More